Gerda Egger

10.4k total citations · 2 hit papers
66 papers, 6.8k citations indexed

About

Gerda Egger is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Gerda Egger has authored 66 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 13 papers in Cancer Research and 12 papers in Oncology. Recurrent topics in Gerda Egger's work include Epigenetics and DNA Methylation (27 papers), Histone Deacetylase Inhibitors Research (13 papers) and Cancer-related gene regulation (10 papers). Gerda Egger is often cited by papers focused on Epigenetics and DNA Methylation (27 papers), Histone Deacetylase Inhibitors Research (13 papers) and Cancer-related gene regulation (10 papers). Gerda Egger collaborates with scholars based in Austria, United States and United Kingdom. Gerda Egger's co-authors include Peter A. Jones, Gangning Liang, Ana M. Aparicio, Yoshimasa Saito, Jody C. Chuang, Jeffrey M. Friedman, Gerhard A. Coetzee, Einav Nili Gal‐Yam, Christine B. Yoo and Joy Lin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Gerda Egger

65 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetics in human disease and prospects for epigenetic therapy

2004 2.4k citations Gerda Egger, Gangning Liang et al. profile →
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells

2006 1.0k citations Yoshimasa Saito, Gangning Liang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerda Egger Austria	30	5.5k	1.7k	832	650	445	66	6.8k
Agustín F. Fernández Spain	44	5.6k 1.0×	2.3k 1.4×	817 1.0×	890 1.4×	629 1.4×	117	7.4k
Peter J. Leedman Australia	50	3.8k 0.7×	2.0k 1.2×	553 0.7×	812 1.2×	687 1.5×	128	7.5k
Johnathan R. Whetstine United States	34	8.7k 1.6×	1.1k 0.7×	1.3k 1.5×	805 1.2×	442 1.0×	51	9.9k
Xiaojing Yang China	33	4.0k 0.7×	1.4k 0.8×	503 0.6×	499 0.8×	322 0.7×	96	5.0k
Johannes H. Schulte Germany	42	4.3k 0.8×	2.1k 1.2×	437 0.5×	1.3k 1.9×	520 1.2×	176	6.3k
Torben A. Kruse Denmark	39	2.7k 0.5×	979 0.6×	1.1k 1.3×	565 0.9×	475 1.1×	214	5.2k
Maxwell P. Lee United States	33	3.8k 0.7×	714 0.4×	1.3k 1.6×	778 1.2×	417 0.9×	89	4.9k
Jinghui Zhang United States	42	3.5k 0.6×	988 0.6×	728 0.9×	1.0k 1.6×	695 1.6×	218	6.4k
Holger Heyn Spain	43	4.9k 0.9×	1.3k 0.7×	1.1k 1.3×	704 1.1×	681 1.5×	80	6.2k
Ji‐Fan Hu United States	44	4.6k 0.8×	1.8k 1.1×	1.4k 1.7×	546 0.8×	509 1.1×	145	6.3k

Countries citing papers authored by Gerda Egger

Since Specialization

Citations

This map shows the geographic impact of Gerda Egger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerda Egger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerda Egger more than expected).

Fields of papers citing papers by Gerda Egger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerda Egger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerda Egger. The network helps show where Gerda Egger may publish in the future.

Co-authorship network of co-authors of Gerda Egger

This figure shows the co-authorship network connecting the top 25 collaborators of Gerda Egger. A scholar is included among the top collaborators of Gerda Egger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerda Egger. Gerda Egger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matthews, Jamie D., Fabio Iannelli, Heinz Fischer, et al.. (2025). HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy. Leukemia. 39(6). 1412–1424. 1 indexed citations

Tran, Loan, et al.. (2024). A systematic review on the culture methods and applications of 3D tumoroids for cancer research and personalized medicine. Cellular Oncology. 48(1). 1–26. 7 indexed citations

Spielvogel, Clemens P., Gerda Egger, Gero Kramer, et al.. (2024). Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer—a cross-sectional study. European Journal of Nuclear Medicine and Molecular Imaging. 51(9). 2833–2842. 7 indexed citations

Tran, Loan, Joachim Friske, Thomas H. Helbich, et al.. (2024). An in vivo tumour organoid model based on the chick embryonic chorioallantoic membrane mimics key characteristics of the patient tissue: a proof-of-concept study. EJNMMI Research. 14(1). 86–86. 2 indexed citations

Miccolo, Claudia, Mirko Doni, Gerda Egger, et al.. (2024). The domesticated transposon protein L1TD1 associates with its ancestor L1 ORF1p to promote LINE-1 retrotransposition. eLife. 13. 2 indexed citations

Friske, Joachim, Thomas Wanek, Lukas Nics, et al.. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging. Cancers. 14(22). 5549–5549. 5 indexed citations

Hassler, Melanie R., et al.. (2022). Quantitative Acetylomics Uncover Acetylation-Mediated Pathway Changes Following Histone Deacetylase Inhibition in Anaplastic Large Cell Lymphoma. Cells. 11(15). 2380–2380. 6 indexed citations

Balber, Theresa, et al.. (2022). Experimental Nuclear Medicine Meets Tumor Biology. Pharmaceuticals. 15(2). 227–227. 6 indexed citations

Pecoraro, Matteo, Heidi A. Neubauer, Karolína Trachtová, et al.. (2021). Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer. Cancers. 13(23). 6036–6036. 4 indexed citations

10.

Pulverer, Walter, et al.. (2021). Multiplexed DNA Methylation Analysis in Colorectal Cancer Using Liquid Biopsy and Its Diagnostic and Predictive Value. Current Issues in Molecular Biology. 43(3). 1419–1435. 18 indexed citations

11.

Hoareau‐Aveilla, Coralie, Marie Tosolini, Patrick Villarèse, et al.. (2020). ALK-transformed mature T lymphocytes restore early thymus progenitor features. Journal of Clinical Investigation. 130(12). 6395–6408. 9 indexed citations

12.

Laengle, Johannes, et al.. (2020). Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis. Journal for ImmunoTherapy of Cancer. 8(1). e000195–e000195. 34 indexed citations

13.

Vesely, Paul, Brigitte Hantusch, Michaela Schlederer, et al.. (2009). Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proceedings of the National Academy of Sciences. 106(48). 20423–20428. 57 indexed citations

14.

Jeong, Shinwu, Gangning Liang, Shikhar Sharma, et al.. (2009). Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA. Molecular and Cellular Biology. 29(19). 5366–5376. 144 indexed citations

15.

Yoo, Christine B., Jody C. Chuang, Hyang‐Min Byun, et al.. (2008). Long-term Epigenetic Therapy with Oral Zebularine Has Minimal Side Effects and Prevents Intestinal Tumors in Mice. Cancer Prevention Research. 1(4). 233–240. 70 indexed citations

16.

Egger, Gerda, et al.. (2007). Inhibition of Histone Deacetylation Does Not Block Resilencing of p16 after 5-Aza-2′-Deoxycytidine Treatment. Cancer Research. 67(1). 346–353. 54 indexed citations

17.

Egger, Gerda, Shinwu Jeong, Connie C. Cortez, et al.. (2006). Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proceedings of the National Academy of Sciences. 103(38). 14080–14085. 166 indexed citations

18.

Gal‐Yam, Einav Nili, Shinwu Jeong, Amos Tanay, et al.. (2006). Constitutive Nucleosome Depletion and Ordered Factor Assembly at the GRP78 Promoter Revealed by Single Molecule Footprinting. PLoS Genetics. 2(9). e160–e160. 57 indexed citations

19.

Cortez, Connie C., Gangning Liang, Jia Li, et al.. (2006). RUNX3: Promoter 1 methylation status. Cancer Research. 66. 372–372. 1 indexed citations

20.

Zupkovitz, Gordin, Julia Tischler, Markus Posch, et al.. (2006). Negative and Positive Regulation of Gene Expression by Mouse Histone Deacetylase 1. Molecular and Cellular Biology. 26(21). 7913–7928. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact